Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Home Visits and Telephone-Supported Education for Adults With Type 2 Diabetes

15 de noviembre de 2026 actualizado por: Saglik Bilimleri Universitesi

Effects of Home Visits and Telephone-Supported Educational Interventions on Diabetes Knowledge, Self-Care Behaviors, and Diabetes-Related Difficulties in Individuals With Type 2 Diabetes Attending a Family Health Center

This study aims to evaluate the effects of home visits and telephone-supported education on diabetes knowledge, self-care behaviors, and diabetes-related difficulties in adults with type 2 diabetes attending a family health center in Türkiye. The study will examine whether these educational approaches help participants better understand their diabetes, manage daily self-care, and cope with difficulties related to living with diabetes.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

90

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Istanbul
      • Istanbul, Istanbul, Turquía (Türkiye), 34035
        • Reclutamiento
        • Şehit İbrahim Ceylan Aile Sağlığı Merkezi
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Aged 18-65 years. Diagnosed with type 2 diabetes mellitus for at least 6 months. Able to read and understand Turkish. No health condition that impairs cognition or communication. Owns a smartphone. Uses insulin, oral antidiabetic medication, or both. Willing to participate in the study.

Exclusion Criteria:

Pregnancy. Inability to complete the data collection instruments due to a cognitive or psychiatric condition.

Unwillingness to participate in the study.

-

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Home Visit-Based Education

Participants in this group will receive nurse-led diabetes education through home visits. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.

A nurse will provide four structured, face-to-face diabetes education sessions in participants' homes, once weekly for four weeks. Each visit will last approximately 45-60 minutes and use PowerPoint presentations, informational brochures, direct instruction, and questions and answers. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change.

Experimental: Telephone-Supported Education

Participants in this group will receive nurse-led, telephone-supported diabetes education. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.

A nurse will provide four structured tele-nursing sessions over one month, once weekly, using telephone calls, video calls, and digital educational materials, including PowerPoint presentations and brochures. Each session will last approximately 15-25 minutes, with additional counseling time when needed. The educational content will be similar to that provided to the home visit group. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. Sessions will reinforce learning, support motivation, and address individual self-care needs.

Sin intervención: Usual Care Control Group

Participants in this group will continue to receive usual care at the family health center. They will not receive the study-specific home visit-based or telephone-supported educational interventions during the study period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Diabetes Health-Promoting Self-Care Behaviors
Periodo de tiempo: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in self-care behaviors will be assessed using the Turkish version of the Diabetes Health-Promoting Self-Care Scale. The scale includes 27 items across seven domains: interpersonal relationships, personal health responsibility, diet, exercise, foot care, blood glucose self-monitoring, and adherence to the recommended regimen. Each item is scored from 1 to 5, giving a total score of 27-135. Higher scores indicate better health-promoting self-care behaviors.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes Knowledge
Periodo de tiempo: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in diabetes knowledge will be assessed using the 28-item Adult Diabetes Knowledge Scale developed by Yavuz and Erol. Each correct answer receives 1 point; incorrect and "I do not know" responses receive 0 points. Total scores range from 0 to 28, with higher scores indicating greater diabetes knowledge.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes-Related Difficulties
Periodo de tiempo: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in diabetes-related difficulties will be assessed using the 30-item Type 2 Diabetes Strengths and Difficulties Scale developed by Bilgehan and Inkaya. The scale assesses difficulties related to lack of knowledge, individual difficulties, and psychosocial difficulties. Each item is scored from 1 (never experience difficulty) to 5 (always experience difficulty), giving a total score of 30-150. Higher scores indicate greater diabetes-related difficulties.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de noviembre de 2026

Finalización primaria (Estimado)

31 de marzo de 2027

Finalización del estudio (Estimado)

31 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

15 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

15 de noviembre de 2026

Publicado por primera vez (Actual)

19 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

15 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

There is currently no plan to share individual participant data with other researchers.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir